ReviewCancers2023

Clinical Impact of New Treatment Strategies for HER2-Positive Metastatic Breast Cancer Patients with Resistance to Classical Anti-HER Therapies.

Marta Tapia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.